290650.KQ Overview

Company Profile

L&C BIO Co.,LTD operates as a research and development company in tissue regeneration medicine. The company offers pharmaceuticals, human tissue, medical device, and cosmetics products. L&C BIO Co.,LTD was founded in 2011 and is headquartered in Seongnam-si, South Korea.

Related stocks

491000.KQ

491000.KQ • South Korea

37,500 KRW

699.74M USD

2697.HK

2697.HK • China

183 HKD

1.2B USD

2675.HK

2675.HK • China

33 HKD

1.64B USD

AVR

AVR • Australia

Anteris Technologies Global Cor

6.77 USD

659.01M USD 1Y +38.7%

214150.KQ

214150.KQ • South Korea

30,350 KRW

1.48B USD 1Y -38.6%

137310.KS

137310.KS • South Korea

6,410 KRW

572.2M USD 1Y -36.3%

7799.TW

7799.TW • Taiwan

HERON NEUTRON MEDICAL CORP.

518 TWD

2.57B USD 1Y -14.7%

4DX.AX

4DX.AX • Australia

4DMEDICAL FPO [4DX]

4.05 AUD

1.7B USD 1Y +73.8%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

5 Metrics

Country

Region

Sector

Industry

Medical Devices

Website

https://www.lncbio.co.kr

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

62.3% p.a.

Max Drawdown (5Y)

-64.9%

Sharpe Ratio (5Y)

0.11

Beta Factor

1.51

Size Class

Mega Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Unprofitable business model: The company is currently generating net losses.

High market risk: Beta of 1.51 indicates above-average volatility compared to the broader market.

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections

Elevated Short-Term Volatility: 3Y volatility (69.3%) is noticeably higher than the 5Y average (62.3%).

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (62.3% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -70.6% in the extended horizon.